Pharmacokinetics, toxicities, and tissue concentrations of belotecan sprayed by rotational intraperitoneal pressurized aerosol chemotherapy in a pig model
Authors:
- Seungmee LeeSLSeungmee Lee
- Seoyoon LeeSLSeoyoon Lee
- Yoo-Kyung SongYSYoo-Kyung Song
- Se-Mi KimSKSe-Mi Kim
- Yoon Jeong ChoiYCYoon Jeong Choi
- Seung Jun LeeSLSeung Jun Lee
- San-Hui LeeSLSan-Hui Lee
- Hee Seung KimHKHee Seung Kim
- on behalf of the KoRIA Trial GroupOGon behalf of the KoRIA Trial Group
Open Access
- 1 January 2025
- journal article
- research article
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36 (3)
Abstract
Lee S, et al. J Gynecol Oncol. 2024 Nov;36:e37. https://doi.org/10.3802/jgo.2025.36.e37Keywords
Funding Information
- Ministry of Science and ICT (2710019525)
- Accelerator Investment-Driven Tech Incubator Program for Startup (RS-2024-00441788)
- Seoul National University Hospital (0620211700, 0320232140, 0320212060)
This publication has 38 references indexed in Scilit:
- Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastasesEBioMedicine, 2022
- Asian perspective on debulking surgery for advanced ovarian cancer: An E-surveyEuropean Journal of Surgical Oncology, 2021
- A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancersEuropean Journal of Cancer, 2020
- A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosisGynecologic Oncology, 2018
- Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancerCancer Chemotherapy and Pharmacology, 2010
- Phase 2 study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal carcinomaCancer, 2008
- Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancerGynecologic Oncology, 2008
- Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancersGynecologic Oncology, 2008
- A phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancerEuropean Journal of Cancer, 2005
- Antitumor activity of 7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin, CKD602, as a potent DNA topoisomerase I inhibitorArchives of Pharmacal Research, 1998